<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00120237</url>
  </required_header>
  <id_info>
    <org_study_id>2.4.4</org_study_id>
    <nct_id>NCT00120237</nct_id>
  </id_info>
  <brief_title>Misoprostol for the Prevention of Postpartum Hemorrhage in Rural Pakistan</brief_title>
  <official_title>A Placebo-Controlled Randomized Trial of Misoprostol in the Management of the Third Stage of Labor in the Home Delivery Setting in Rural Pakistan</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gynuity Health Projects</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Aga Khan University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Aga Khan Health Services</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Aga Khan Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Family Care International</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Gynuity Health Projects</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This community-based trial will study misoprostol for the prevention of postpartum hemorrhage
      in rural Pakistan. Traditional birth attendants assisting home deliveries will administer
      study tablets (600 mcg oral misoprostol or placebo) in the third stage of labor to women
      participating in the trial. Blood loss, hemoglobin levels, side effects, and other variables
      will be evaluated.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2005</start_date>
  <completion_date type="Actual">July 2008</completion_date>
  <primary_completion_date type="Actual">July 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postpartum hemorrhage (blood loss &gt;or= 500 mL)</measure>
    <time_frame>Measured at 1 hour postpartum or until active bleeding has stopped</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Drop in hemoglobin &gt; 2 g/dL from pre to post-delivery</measure>
    <time_frame>Hemoblobin (Hb) level measured 3-5 days after delivery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intermediate and severe PPH (blood loss &gt;or=750 mL and &gt;or= than 1000 mL)</measure>
    <time_frame>Blood loss measured at 1 hr postpartum or until active bleeding stopped</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean blood loss</measure>
    <time_frame>blood loss measured at 1 hr postpartum or until active bleeding stopped</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Side effects experienced among recently delivered mothers</measure>
    <time_frame>Interviews conducted 1 day post-delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anemia (&lt;9 g/dL and &lt;11 g/dL)</measure>
    <time_frame>Postpartum hemoglobin assessed 3 days post-delivery</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">1600</enrollment>
  <condition>Postpartum Hemorrhage</condition>
  <condition>Anemia</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Misoprostol</intervention_name>
    <description>600 mcg oral misoprostol administered during third stage of labor</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant women in general good health, home delivery

          -  Must live in one of 78 study villages

        Exclusion Criteria:

          -  Hypertension

          -  Non-cephalic presentation

          -  Polyhydramnios

          -  Previous cesarean section

          -  Suspected multiple pregnancy

          -  Suspected still birth

          -  Antepartum hemorrhage

          -  Previous complication in 3rd trimester

          -  Anemia of &lt;8 g/dl
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gijs Walraven, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aga Khan Health Services</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Juanita Hatcher, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aga Khan University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Naushaba Mobeen, MD</last_name>
    <role>Study Director</role>
    <affiliation>Aga Khan University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jennifer Blum, MPH</last_name>
    <role>Study Director</role>
    <affiliation>Gynuity Health Projects</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Zafar Ahmad, MD</last_name>
    <role>Study Director</role>
    <affiliation>Aga Khan Health Services</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nadeem Zuberi, MD</last_name>
    <role>Study Director</role>
    <affiliation>Aga Khan University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jill Durocher</last_name>
    <role>Study Director</role>
    <affiliation>Gynuity Health Projects</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Home delivery setting</name>
      <address>
        <city>Chitral</city>
        <state>Chitral District</state>
        <country>Pakistan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Pakistan</country>
  </location_countries>
  <link>
    <url>http://www.gynuity.org</url>
    <description>Gynuity Health Projects</description>
  </link>
  <verification_date>March 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 7, 2005</study_first_submitted>
  <study_first_submitted_qc>July 7, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 15, 2005</study_first_posted>
  <last_update_submitted>March 17, 2009</last_update_submitted>
  <last_update_submitted_qc>March 17, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 19, 2009</last_update_posted>
  <responsible_party>
    <name_title>Gynuity Health Projects</name_title>
    <organization>Gynuity Health Projects</organization>
  </responsible_party>
  <keyword>Postpartum hemorrhage</keyword>
  <keyword>Misoprostol</keyword>
  <keyword>Maternal morbidity</keyword>
  <keyword>Developing countries</keyword>
  <keyword>Traditional birth attendants</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Postpartum Hemorrhage</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Misoprostol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

